EUVIMEDEUVIMED entdecken
Crossref

The Adverse Effects of Thalassemia Treatments Including Blood Transfusion and Main Pharmacological Therapies

Mohammadreza Sattari, Dorna Sheykhi, Alireza Nikanfar, Abasali Hosseyn Pourfeizi, Maryam Nazari, Roya Dolatkhah, Hadi Hamishehkar, Simin Ozar Mashayekhi

Research at the University of Copenhagen (University of Copenhagen) · 30.06.2026 · 18 (4) · 199-204

DOI: 10.13140/rg.2.2.29993.15206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research at the University of Copenhagen (University of Copenhagen), erschienen am 30.06.2026. Verfasst von Mohammadreza Sattari und 7 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A B S T R A C T Background: Beta-thalassemia major (β-TM) is a disorder which needs lifelong blood transfusions. Our aim was to examine the treatments side effects in thalassemic patients.

Methods

110 β-TM patients attending two centers were invited to the study. Those who consented were asked to complete a questionnaire. The questionnaire covered demographical information, used medications and their side effects. The data was analyzed using SPSS software version 14.

Results

Data was collected between August 2008 and July 2009. Patients' age was 14.0±1.32 years. The duration of treatment was 11.3±7.5 years. Thalassemic patients received blood transfusions, deferoxamine and supportive medications. Number of medications, received by patients was 3.9±1.9. Hemosiderosis in heart (11%) and endocrine system (8%) were main blood transfusion side effects. A few had hepatitis B or C.

Conclusion

Because of prevalence of side effects of therapies, reviewing and improving treatment protocol by designing new medicines with lower side effects and establishment of an adverse reactions team seemed necessary.

Schlagwörter

beta-thalassemia majorblood transfusionadverse drug reactionsdeferoxaminehemosiderosisendocrine complicationshepatitis Bhepatitis Cpediatric patientssupportive therapy

Zitieren

APA

Sattari, M., Sheykhi, D., Nikanfar, A., Pourfeizi, A. H., Nazari, M., Dolatkhah, R., Hamishehkar, H., & Mashayekhi, S. O. (2026). The Adverse Effects of Thalassemia Treatments Including Blood Transfusion and Main Pharmacological Therapies. Research at the University of Copenhagen (University of Copenhagen), 18(4), 199-204. https://doi.org/10.13140/rg.2.2.29993.15206

Vancouver

Sattari M, Sheykhi D, Nikanfar A, Pourfeizi AH, Nazari M, Dolatkhah R, et al. The Adverse Effects of Thalassemia Treatments Including Blood Transfusion and Main Pharmacological Therapies. Research at the University of Copenhagen (University of Copenhagen). 2026;18(4):199-204. doi:10.13140/rg.2.2.29993.15206

BibTeX
@article{Sattari2026,
  author = {Sattari, Mohammadreza and Sheykhi, Dorna and Nikanfar, Alireza and Pourfeizi, Abasali Hosseyn and Nazari, Maryam and Dolatkhah, Roya and Hamishehkar, Hadi and Mashayekhi, Simin Ozar},
  title = {The Adverse Effects of Thalassemia Treatments Including Blood Transfusion and Main Pharmacological Therapies},
  journal = {Research at the University of Copenhagen (University of Copenhagen)},
  year = {2026},
  volume = {18},
  number = {4},
  pages = {199--204},
  doi = {10.13140/rg.2.2.29993.15206}
}
Kostenlos starten →